참고문헌
- Vanier MT and Millat G (2003) Niemann-Pick disease type C. Clin Genet 64, 269-281 https://doi.org/10.1034/j.1399-0004.2003.00147.x
- Lee H, Lee JK, Park MH et al (2014) Pathological roles of the VEGF/SphK pathway in Niemann-Pick type C neurons. Nat Commun 5, 5514 https://doi.org/10.1038/ncomms6514
- Pentchev PG, Comly ME, Kruth HS et al (1985) A defect in cholesterol esterification in Niemann-Pick disease (type C) patients. Proc Natl Acad Sci U S A 82, 8247-8251 https://doi.org/10.1073/pnas.82.23.8247
- Karten B, Vance DE, Campenot RB and Vance JE (2002) Cholesterol accumulates in cell bodies, but is decreased in distal axons, of Niemann-Pick C1-deficient neurons. J Neurochem 83, 1154-1163 https://doi.org/10.1046/j.1471-4159.2002.01220.x
- Sarna JR, Larouche M, Marzban H, Sillitoe RV, Rancourt DE and Hawkes R (2003) Patterned Purkinje cell degeneration in mouse models of Niemann-Pick type C disease. J Comp Neurol 456, 279-291 https://doi.org/10.1002/cne.10522
- Bae JS, Furuya S, Ahn SJ, Yi SJ, Hirabayashi Y and Jin HK (2005) Neuroglial activation in Niemann-Pick Type C mice is suppressed by intracerebral transplantation of bone marrow-derived mesenchymal stem cells. Neurosci Lett 381, 234-236 https://doi.org/10.1016/j.neulet.2005.02.029
- Zhang XM, Ng AH, Tanner JA et al (2004) Highly restricted expression of Cre recombinase in cerebellar Purkinje cells. Genesis 40, 45-51 https://doi.org/10.1002/gene.20062
- Elrick MJ, Pacheco CD, Yu T et al (2010) Conditional Niemann-Pick C mice demonstrate cell autonomous Purkinje cell neurodegeneration. Hum Mol Genet 19, 837-847 https://doi.org/10.1093/hmg/ddp552
- Lange C, Storkebaum E, de Almodovar CR, Dewerchin M and Carmeliet P (2016) Vascular endothelial growth factor: a neurovascular target in neurological diseases. Nat Rev Neurol 12, 439-454
- Licht T, Goshen I, Avital A et al (2011) Reversible modulations of neuronal plasticity by VEGF. Proc Natl Acad Sci U S A 108, 5081-5086 https://doi.org/10.1073/pnas.1007640108
- Giaume C, Kirchhoff F, Matute C, Reichenbach A and Verkhratsky A (2007) Glia: the fulcrum of brain diseases. Cell Death Differ 14, 1324-1335 https://doi.org/10.1038/sj.cdd.4402144
- Nimmerjahn A (2009) Astrocytes going live: advances and challenges. J Physiol 587, 1639-1647 https://doi.org/10.1113/jphysiol.2008.167171
- Baudry M, Yao Y, Simmons D, Liu J and Bi X (2003) Postnatal development of inflammation in a murine model of Niemann-Pick type C disease: immunohistochemical observations of microglia and astroglia. Exp Neurol 184, 887-903 https://doi.org/10.1016/S0014-4886(03)00345-5
- German DC, Liang CL, Song T, Yazdani U, Xie C and Dietschy JM (2002) Neurodegeneration in the Niemann- Pick C mouse: glial involvement. Neuroscience 109, 437-450 https://doi.org/10.1016/S0306-4522(01)00517-6
- Patel SC, Suresh S, Kumar U et al (1999) Localization of Niemann-Pick C1 protein in astrocytes: implications for neuronal degeneration in Niemann- Pick type C disease. Proc Natl Acad Sci U S A 96, 1657-1662 https://doi.org/10.1073/pnas.96.4.1657
- Lopez ME, Klein AD, Dimbil UJ and Scott MP (2011) Anatomically defined neuron-based rescue of neurodegenerative Niemann-Pick type C disorder. J Neurosci 31, 4367-4378 https://doi.org/10.1523/JNEUROSCI.5981-10.2011
- Yu T, Shakkottai VG, Chung C and Lieberman AP (2011) Temporal and cell-specific deletion establishes that neuronal Npc1 deficiency is sufficient to mediate neurodegeneration. Hum Mol Genet 20, 4440-4451 https://doi.org/10.1093/hmg/ddr372
- Vanier MT (2010) Niemann-Pick disease type C. Orphanet J Rare Dis 5, 16 https://doi.org/10.1186/1750-1172-5-16
- Davidson CD, Ali NF, Micsenyi MC et al (2009) Chronic cyclodextrin treatment of murine Niemann-Pick C disease ameliorates neuronal cholesterol and glycosphingolipid storage and disease progression. PLoS One 4, e6951 https://doi.org/10.1371/journal.pone.0006951
-
Lopez AM, Terpack SJ, Posey KS, Liu B, Ramirez CM and Turley SD (2014) Systemic administration of 2-hydroxypropyl-
${\beta}$ -cyclodextrin to symptomatic Npc1-deficient mice slows cholesterol sequestration in the major organs and improves liver function. Clin Exp Pharmacol Physiol 41, 780-787 https://doi.org/10.1111/1440-1681.12285 - Camargo F, Erickson RP, Garver WS et al (2001) Cyclodextrins in the treatment of a mouse model of Niemann-Pick C disease. Life Sci 70, 131-142 https://doi.org/10.1016/S0024-3205(01)01384-4
- Hovakimyan M, Maass F and Petersen J (2013) Combined therapy with cyclodextrin/allopregnanolone and miglustat improves motor but not cognitive functions in Niemann-Pick Type C1 mice. Neuroscience 252, 201-211 https://doi.org/10.1016/j.neuroscience.2013.08.001
- Williams IM, Wallom KL, Smith DA, Al Eisa N, Smith C, Platt FM (2014) Improved neuroprotection using miglustat, curcumin and ibuprofen as a triple combination therapy in Niemann-Pick disease type C1 mice. Neurobiol Dis 67, 9-17 https://doi.org/10.1016/j.nbd.2014.03.001
- Gerber HP, Hillan KJ, Ryan AM et al (1999) VEGF is required for growth and survival in neonatal mice. Development 126, 1149-1159
- Wang Y, Kilic E, Kilic U et al (2005) VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena. Brain 128, 52-63
- Tabata T, Sawada S, Araki K, Bono Y, Furuya S and Kano M (2000) A reliable method for culture of dissociated mouse cerebellar cells enriched for Purkinje neurons. J Neurosci Methods 104, 45-53 https://doi.org/10.1016/S0165-0270(00)00323-X